ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Efficacy of Antiviral Treatment for Chronic Hepatitis B Patients with Normal ALT Levels: A Systematic Review and Meta-analysis

Qian, Zhe; Hu, Meixin; Wu, Houji; Chen, Hongjie; Liao, Guichan; Kang, Zixin; Lin, Xiaoli; Peng, Jie*南方医科大学
Hepatitis Monthly2022-12DOI: 10.5812/hepatmon-129836
7阅读
引用收藏
分享

摘要

Context: When nucleos(t)ide analogues (NAs) were applied clinically to manage chronic hepatitis B virus infection, the prognosis of chronic hepatitis B (CHB) patients greatly improved. However, certain CHB patients with normal alanine aminotransferase (ALT) levels were not used to be considered as the population with the need for antiviral treatment. @@@ Objectives: This systematic review and meta-analysis collected and analyzed data from clinical trials to assess and compare the efficacy of antiviral treatment among patients with elevated and normal ALT levels. @@@ Methods: A systematic search was performed to gather studies published from 1990.01 to 2022.08 in PubMed and Web of Science databases. The quality of the literaturewasassessed, and16 studies were included for further analysis. Basic informationonincluded studies and study populations was collected. A meta-analysis was carried out to evaluate three major outcomes of viral response, hepatitis B envelope antigen (HBeAg) loss, and HBeAg seroconversion after NAs treatment based on data extracted from these studies. Odds ratios (ORs) with 95% confidence intervals (CIs) for all outcomes were calculated using fixed-effects models. @@@ Results: In the 16 relevant studies, 5,345 patients met the inclusion criteria, including 3,687 patients receiving NAs treatment. All patients were grouped into one with elevated ALT and another with normal ALT based on whether their pretreatment ALT levels > 1*upper limit of normal (ULN). For patients receiving lamivudine, the viral response showed no significant difference between the groups with elevated and normal ALT levels (pooled log OR: 0.51 [-0.23 - 1.26], P = 0.79); the pooled log OR for HBeAg loss was 1.19 (0.63 - 1.76, P = 0.03) and pooled log OR for HBeAg seroconversion was 2.19 (0.91 - 3.47, P = 0.40). For patients receiving first-line therapy with tenofovir disoproxil fumarate (TDF) and entecavir (ETV), the viral response showed no significant difference between the two groups: Pooled log OR (0.38 [-0.22 - 0.97], P = 0.10). The pooled log OR for HBeAg loss and HBeAg seroconversion was (-0.07 [-0.81 0.67], P = 0.68) and (0.40 [-0.84 - 1.63], P = 0.88), respectively. @@@ Conclusions: The efficacies of first-line therapy with TDF and ETV treatments were similar in groups with elevated and normal ALT levels for the outcomes of viral response and HBeAg loss. These findingsmaysupport further treatment of CHBpatients with normal ALT levels.

学科与关键词

关键词
Alanine Aminotransferase (ALT)Chronic HBV InfectionAntiviral AgentsNAs
相关
加载中…
  • Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study
    Wei, Sufang; Hu, Meixin; Chen, Hongjie; Xie, Qiuli; Wang, Peng; Li, Hong; Peng, Jie*BMC GASTROENTEROLOGY, 2022, 22(1): 387.被引 1
  • Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study
    Hu, Meixin; Liao, Guichan; Wei, Sufang; Qian, Zhe; Chen, Hongjie; Xia, Muye; Xie, Qiuli; Peng, Jie*Infectious Diseases and Therapy, 2023, 12(2): 637-647.
  • Comparison of Efficacy and Safety of Tenofovir and Entecavir in Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis
    Ke Weixia; Liu Li; Zhang Chi; Ye Xiaohua; Gao Yanhui; Zhou Shudong; Yang Yi*PLoS ONE, 2014, 9(6): e98865.
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatitis Monthly
发表日期
2022-12
卷期
第 22 卷, 第 1 期
页码
e129836
DOI
10.5812/hepatmon-129836
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Clinical Research Startup Program of Southern Medical University; High-level University Construction Funding from the Guangdong Provincial Department of Education [LC2016PY003]; scientific research project of Guangdong Provincial Administration of Traditional Chinese Medicine [20211088]

作者

  • Q

    Qian, Zhe (第一作者)

    southern med univ

  • H

    Hu, Meixin

    southern med univ

查看全部 8 位作者收起作者
  • W

    Wu, Houji

    southern med univ

  • C

    Chen, Hongjie

    southern med univ

  • L

    Liao, Guichan

    southern med univ

  • K

    Kang, Zixin

    southern med univ

  • L

    Lin, Xiaoli

    southern med univ

  • P

    Peng, Jie (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417